Literature DB >> 32523780

Material design for lymph node drug delivery.

Alex Schudel1,2,3, David M Francis2,4,3, Susan N Thomas2,5,6,7.   

Abstract

A significant fraction of the total immune cells in the body are located in several hundred lymph nodes, in which lymphocyte accumulation, activation and proliferation are organized. Therefore, targeting lymph nodes provides the possibility to directly deliver drugs to lymphocytes and lymph node-resident cells and thus to modify the adaptive immune response. However, owing to the structure and anatomy of lymph nodes, as well as the distinct localization and migration of the different cell types within the lymph node, it is difficult to access specific cell populations by delivering free drugs. Materials can be used as instructive delivery vehicles to achieve accumulation of drugs in the lymph nodes and to target specific lymph node-resident cell subtypes. In this Review, we describe the compartmental architecture of lymph nodes and the cell and fluid transport mechanisms to and from lymph nodes. We discuss the different entry routes into lymph nodes and how they can be explored for drug delivery, including the lymphatics, blood capillaries, high endothelial venules, cell-mediated pathways, homing of circulating lymphocytes and direct lymph node injection. We examine different nanoscale and microscale materials for the targeting of specific immune cells and highlight their potential for the treatment of immune dysfunction and for cancer immunotherapy. Finally, we give an outlook to the field, exploring how lymph node targeting can be improved by the use of materials.

Entities:  

Year:  2019        PMID: 32523780      PMCID: PMC7286627          DOI: 10.1038/s41578-019-0110-7

Source DB:  PubMed          Journal:  Nat Rev Mater        ISSN: 2058-8437            Impact factor:   66.308


  59 in total

Review 1.  Enhancing cancer immunotherapy with nanomedicine.

Authors:  Darrell J Irvine; Eric L Dane
Journal:  Nat Rev Immunol       Date:  2020-01-31       Impact factor: 53.106

Review 2.  Nanoparticle-based approaches to target the lymphatic system for antitumor treatment.

Authors:  Xingzhou Peng; Junjie Wang; Feifan Zhou; Qian Liu; Zhihong Zhang
Journal:  Cell Mol Life Sci       Date:  2021-05-08       Impact factor: 9.261

Review 3.  Information flow in the spatiotemporal organization of immune responses.

Authors:  Jessica Y Huang; Miranda R Lyons-Cohen; Michael Y Gerner
Journal:  Immunol Rev       Date:  2021-11-29       Impact factor: 12.988

Review 4.  Cell and tissue engineering in lymph nodes for cancer immunotherapy.

Authors:  Alexander J Najibi; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2020-08-01       Impact factor: 15.470

Review 5.  Immunoengineering has arrived.

Authors:  Jordan J Green
Journal:  J Biomed Mater Res A       Date:  2020-08-04       Impact factor: 4.396

6.  Quantitation of lymphatic transport mechanism and barrier influences on lymph node-resident leukocyte access to lymph-borne macromolecules and drug delivery systems.

Authors:  Paul A Archer; Lauren F Sestito; Margaret P Manspeaker; Meghan J O'Melia; Nathan A Rohner; Alex Schudel; Yajun Mei; Susan N Thomas
Journal:  Drug Deliv Transl Res       Date:  2021-06-24       Impact factor: 4.617

7.  Exploiting Rational Assembly to Map Distinct Roles of Regulatory Cues during Autoimmune Therapy.

Authors:  Robert S Oakes; Lisa H Tostanoski; Senta M Kapnick; Eugene Froimchuk; Sheneil K Black; Xiangbin Zeng; Christopher M Jewell
Journal:  ACS Nano       Date:  2021-03-01       Impact factor: 15.881

8.  Innate cell microenvironments in lymph nodes shape the generation of T cell responses during type I inflammation.

Authors:  Joseph M Leal; Jessica Y Huang; Karan Kohli; Caleb Stoltzfus; Miranda R Lyons-Cohen; Brandy E Olin; Michael Gale; Michael Y Gerner
Journal:  Sci Immunol       Date:  2021-02-12

Review 9.  Employing Drug Delivery Strategies to Overcome Challenges Using TLR7/8 Agonists for Cancer Immunotherapy.

Authors:  Dhruv Varshney; Sherry Yue Qiu; Tyler P Graf; Kevin J McHugh
Journal:  AAPS J       Date:  2021-06-28       Impact factor: 4.009

Review 10.  A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system.

Authors:  Alexandros Marios Sofias; Francis Combes; Steffen Koschmieder; Gert Storm; Twan Lammers
Journal:  Drug Discov Today       Date:  2021-02-19       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.